Sp360
DEBATE: TRADITIONAL VS ENDOSCOPIC APPROACH FOR THE DIAGNOSIS OF NAFLD
Date
May 7, 2023
Explore related products in the following collection:
Society: DDW
LIVE STREAM SESSION
LIVE STREAM SESSION
Presenters
Houston Methodist Hospital
Indiana University School of Medicine
Tracks
Related Products
DUPILUMAB IS EFFICACIOUS IN EOSINOPHILIC ESOPHAGITIS REGARDLESS OF PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY-EOE-TREET STUDY
BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
MULTIMODAL SINGLE CELL ANALYSES REVEAL PATHOGENIC FIBROBLASTS IN PERIANAL FISTULA
BACKGROUND: Perianal fistulae are highly morbid complications of Crohn’s disease (CD) with a cumulative incidence of 20-25%; despite demonstrated efficacy of infliximab treatment, estimates of complete resolution are only 20-30%. Ultimately, 20% of patients will require proctectomy…
THE ROLE OF ENTERIC GLIAL CELLS AND AQP1 IN THE AMELIORATING EFFECT OF ELECTROACUPUNCTURE IN A RODENT MODEL OF VISCERAL HYPERSENSITIVITY
BACKGROUND: Perianal fistulae are highly morbid complications of Crohn’s disease (CD) with a cumulative incidence of 20-25%; despite demonstrated efficacy of infliximab treatment, estimates of complete resolution are only 20-30%. Ultimately, 20% of patients will require proctectomy…
SINGLE-CELL INTESTINAL CHANGES IN PEDIATRIC CROHN'S DISEASE BEFORE AND AFTER ANTI-TNF BLOCKADE.
BACKGROUND: Perianal fistulae are highly morbid complications of Crohn’s disease (CD) with a cumulative incidence of 20-25%; despite demonstrated efficacy of infliximab treatment, estimates of complete resolution are only 20-30%. Ultimately, 20% of patients will require proctectomy…
